194 related articles for article (PubMed ID: 24846673)
1. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2014 Sep; 171(18):4273-88. PubMed ID: 24846673
[TBL] [Abstract][Full Text] [Related]
2. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
3. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.
Khroyan TV; Wu J; Polgar WE; Cami-Kobeci G; Fotaki N; Husbands SM; Toll L
Br J Pharmacol; 2015 Jan; 172(2):668-80. PubMed ID: 24903063
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye.
Knapman A; Connor M
Methods Mol Biol; 2015; 1230():177-85. PubMed ID: 25293325
[TBL] [Abstract][Full Text] [Related]
5. Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants.
Grinnell SG; Ansonoff M; Marrone GF; Lu Z; Narayan A; Xu J; Rossi G; Majumdar S; Pan YX; Bassoni DL; Pintar J; Pasternak GW
Synapse; 2016 Oct; 70(10):395-407. PubMed ID: 27223691
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors.
Wang PC; Ho IK; Lee CW
J Cell Mol Med; 2015 Nov; 19(11):2587-96. PubMed ID: 26153065
[TBL] [Abstract][Full Text] [Related]
7. Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors.
Zhuo GY; Chen MC; Lin TY; Lin ST; Chen DT; Lee CW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674576
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.
Feng B; Li Z; Wang JB
Mol Pharmacol; 2011 Apr; 79(4):768-75. PubMed ID: 21212139
[TBL] [Abstract][Full Text] [Related]
9. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.
Huang P; Chen C; Mague SD; Blendy JA; Liu-Chen LY
Biochem J; 2012 Jan; 441(1):379-86. PubMed ID: 21864297
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor.
Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
van Niel JC; Schneider J; Tzschentke TM
Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
[TBL] [Abstract][Full Text] [Related]
12. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference.
Marquez P; Baliram R; Kieffer BL; Lutfy K
Neuropharmacology; 2007 May; 52(6):1336-41. PubMed ID: 17367825
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
14. Endomorphin-2: a biased agonist at the μ-opioid receptor.
Rivero G; Llorente J; McPherson J; Cooke A; Mundell SJ; McArdle CA; Rosethorne EM; Charlton SJ; Krasel C; Bailey CP; Henderson G; Kelly E
Mol Pharmacol; 2012 Aug; 82(2):178-88. PubMed ID: 22553358
[TBL] [Abstract][Full Text] [Related]
15. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
Beyer A; Koch T; Schröder H; Schulz S; Höllt V
J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
[TBL] [Abstract][Full Text] [Related]
16. μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways.
Cussac D; Rauly-Lestienne I; Heusler P; Finana F; Cathala C; Bernois S; De Vries L
Cell Signal; 2012 Aug; 24(8):1648-57. PubMed ID: 22560877
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
19. The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.
Pil J; Tytgat J
Br J Pharmacol; 2001 Oct; 134(3):496-506. PubMed ID: 11588103
[TBL] [Abstract][Full Text] [Related]
20. Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptor.
Cooke AE; Oldfield S; Krasel C; Mundell SJ; Henderson G; Kelly E
Br J Pharmacol; 2015 Jan; 172(2):593-605. PubMed ID: 24697554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
